These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

882 related items for PubMed ID: 36310708

  • 1. Cuproptosis-related long non-coding RNAs model that effectively predicts prognosis in hepatocellular carcinoma.
    Huang EM, Ma N, Ma T, Zhou JY, Yang WS, Liu CX, Hou ZH, Chen S, Zong Z, Zeng B, Li YR, Zhou TC.
    World J Gastrointest Oncol; 2022 Oct 15; 14(10):1981-2003. PubMed ID: 36310708
    [Abstract] [Full Text] [Related]

  • 2. A Cuproptosis-Related LncRNA Risk Model for Predicting Prognosis and Immunotherapeutic Efficacy in Patients with Hepatocellular Carcinoma.
    Wang S, Bai H, Fei S, Miao B.
    Biochem Genet; 2024 Jun 15; 62(3):2332-2351. PubMed ID: 37898914
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Identification of a cuproptosis and copper metabolism gene-related lncRNAs prognostic signature associated with clinical and immunological characteristics of hepatocellular carcinoma.
    Yuan W, Xiao JH, Zhang JS, Mao BL, Wang PZ, Wang BL.
    Front Oncol; 2023 Jun 15; 13():1153353. PubMed ID: 37056336
    [Abstract] [Full Text] [Related]

  • 6. An integrative analysis revealing cuproptosis-related lncRNAs signature as a novel prognostic biomarker in hepatocellular carcinoma.
    Chen X, Sun M, Feng W, Chen J, Ji X, Xie M, Huang W, Chen X, Zhang B, Nie Y, Fan D, Wu K, Xia L.
    Front Genet; 2023 Jun 15; 14():1056000. PubMed ID: 36845390
    [Abstract] [Full Text] [Related]

  • 7. A cuproptosis-related lncRNA signature for predicting prognosis and immune response in hepatocellular carcinoma.
    Wu J, Yao J, Jia S, Yao X, Shao J, Cao W, Ma S, Yao X, Li H.
    Heliyon; 2023 Sep 15; 9(9):e19352. PubMed ID: 37810122
    [Abstract] [Full Text] [Related]

  • 8. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma.
    Qi X, Guo J, Chen G, Fang C, Hu L, Li J, Zhang C.
    J Immunol Res; 2022 Sep 15; 2022():3393027. PubMed ID: 36438201
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cuproptosis-related lncRNA scoring system to predict the clinical outcome and immune landscape in pancreatic adenocarcinoma.
    Huang Y, Gong P, Su L, Zhang M.
    Sci Rep; 2023 Nov 27; 13(1):20870. PubMed ID: 38012210
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cuproptosis-Related lncRNAs are Biomarkers of Prognosis and Immune Microenvironment in Head and Neck Squamous Cell Carcinoma.
    Yang L, Yu J, Tao L, Huang H, Gao Y, Yao J, Liu Z.
    Front Genet; 2022 Nov 27; 13():947551. PubMed ID: 35938003
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.